Anticardiolipin antibodies in acquired immunodeficiency syndrome
- 1 August 1989
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 149 (8) , 1833-1835
- https://doi.org/10.1001/archinte.149.8.1833
Abstract
• We undertook a prospective study of IgG and IgM anticardiolipin antibodies (ACAs) to determine their clinical significance in patients with acquired immunodeficiency syndrome (AIDS). IgG ACAs were found in 24 (92.3%) of 26 patients with AIDS who were hospitalized for pulmonary complaints (group 1) and in 13 (93%) of 14 patients with AIDS-related complex (group 2). In addition, 17 (94%) of 18 patients with AIDS (group 3) who had coagulation tests and were studied retrospectively had IgG ACAs. The prevalence of IgG ACAs in these three groups was significantly higher than in healthy controls, but was comparable to that in 31 consecutive patients with systemic lupus erythematosus (67.7%). The mean titer of IgG ACAs in group 1 was higher than in groups 2 and 3 but was not different from that in the patients with systemic lupus erythematosus. The frequency and titer of IgM ACAs in group 1 (7.6%) or group 2 (14.3%) were not significantly different from those in normal controls (4.7%). In contrast, half of the patients in group 3 had low-titer IgM ACAs. The serum titer of IgG ACAs in patients with AIDS with thrombocytopenia was significantly higher than it was in those with normal platelet counts. There was no association between ACAs and Pneumocystis carinii pneumonia or other infections, cancer, thrombosis, positive VDRL test, or presence of the lupus anticoagulant. The prevalence and titer of IgG or IgM ACAs were not associated with abnormal results of any coagulation test. Although we found IgG ACAs to be associated with thrombocytopenia in AIDS, their presence does not carry exactly the same clinical significance as it does in systemic lupus erythematosus. The high prevalence of ACAs in AIDS, in AIDS-related complex, and in otherwise healthy contacts with antibodies to human immunodeficiency virus suggests that their occurrence may be related to the underlying human immunodeficiency virus infection. (Arch Intern Med. 1989;149:1833-1835)This publication has 20 references indexed in Scilit:
- The Frequency of Lupus Anticoagulant in Systemic Lupus ErythematosusAnnals of Internal Medicine, 1987
- Circulating Coagulation Inhibitors in the Acquired Immunodeficiency SyndromeAnnals of Internal Medicine, 1986
- Thrombocytopenia in SLE and related autoimmune disorders: association with anticardiolipin antibodyBritish Journal of Haematology, 1985
- Thromboembolism in patients with the 'lupus'-type circulating anticoagulantArchives of internal medicine (1960), 1984
- ANTI-PHOSPHOLIPID ANTIBODIES AND BIOLOGICAL FALSE POSITIVE SEROLOGICAL TEST FOR SYPHILIS IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS1984
- ANTICARDIOLIPIN ANTIBODIES: DETECTION BY RADIOIMMUNOASSAY AND ASSOCIATION WITH THROMBOSIS IN SYSTEMIC LUPUS ERYTHEMATOSUSThe Lancet, 1983
- Recurrent ischemic attacks in two young adults with lupus anticoagulant.Stroke, 1983
- INDUCTION OF ANTIBODY TO ASIALO GM1 BY SPERMATOZOA AND ITS OCCURRENCE IN THE SERA OF HOMOSEXUAL MEN WITH THE ACQUIRED IMMUNE-DEFICIENCY SYNDROME (AIDS)1983
- Thrombosis in Patients with the Lupus AnticoagulantAnnals of Internal Medicine, 1980
- A Sensitive Test Demonstrating Lupus Anticoagulant and its Behavioural PatternsBritish Journal of Haematology, 1978